Atlas Trials

Immunotherapy With Tacrolimus Resistant EBV CTL for Lymphoproliferative Disease After Solid Organ Transplant

Clinical trial NCT03131934 · COMPLETED

Trial details

NCT number
NCT03131934
Sponsor
University College, London
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Post-transplant Lymphoproliferative DiseaseTransplant-Related Hematologic Malignancy
Start date
2019-05-31
Primary completion
2020-06-30
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.